CHAOJU EYE CARE (02219) spent 163,300 Hong Kong dollars to repurchase 60,000 shares on January 22nd.
Chaoju Ophthalmology (02219) announced that on January 22, 2026, the company spent 163,000 Hong Kong dollars to repurchase 60,000 shares at a repurchase price of 2.69-2.75 Hong Kong dollars per share.
CHAOJU EYE CARE (02219) announced that on January 22, 2026, the company spent 163,300 Hong Kong dollars to repurchase 60,000 shares at a repurchase price of 2.69-2.75 Hong Kong dollars per share.
Related Articles
LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.
LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.
MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.
LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.
LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.
MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
